Prosensa to Present at Upcoming Investor Conferences
24. September 2013 13:32 ET
|
Prosensa Holding N.V.
Leiden, The Netherlands, Sept. 24, 2013 (GLOBE NEWSWIRE) -- Prosensa Holding N.V. (NASDAQ: RNA) today
announced presentations at upcoming investor conferences.
Hans GCP Schikan, Chief Executive...
GSK and Prosensa Announce Primary Endpoint Not Met in Phase III Study of Drisapersen in Patients With Duchenne Muscular Dystrophy
20. September 2013 07:00 ET
|
Prosensa Holding N.V.
LONDON and LEIDEN, Netherlands, Sept. 20, 2013 (GLOBE NEWSWIRE) -- GlaxoSmithKline (GSK) and Prosensa today announced that GSK's Phase III clinical study of drisapersen, an investigational antisense...
Prosensa Initiates First Patient Dosing in Phase I/II trial of PRO053
06. September 2013 08:30 ET
|
Prosensa Holding N.V.
Leiden, The Netherlands, Sept. 6, 2013 (GLOBE NEWSWIRE) -- Prosensa Holding N.V. (NASDAQ: RNA), the Dutch
biopharmaceutical company focusing on RNA-modulating therapeutics
for rare diseases with high...
Prosensa Announces Second Quarter 2013 Financial Results and Recent Corporate Developments
28. August 2013 07:00 ET
|
Prosensa Holding N.V.
LEIDEN, The Netherlands, Aug. 28, 2013 (GLOBE NEWSWIRE) -- Prosensa Holding N.V. (Nasdaq:RNA), the Dutch biopharmaceutical company focusing on RNA-modulating therapeutics for rare diseases with high...
Prosensa Holding N.V. to Webcast Conference Call Discussing Second Quarter 2013 Financial Results on August 28, 2013
20. August 2013 08:00 ET
|
Prosensa Holding N.V.
Leiden, The Netherlands, Aug. 20, 2013 (GLOBE NEWSWIRE) --
Prosensa Holding N.V. (NASDAQ: RNA) today announced that the
Company will host a conference call and live audio webcast on
Wednesday, August...
Prosensa to Present at Wedbush 2013 Life Sciences Management Access Conference
06. August 2013 08:00 ET
|
Prosensa Holding N.V.
Leiden, The Netherlands, Aug. 6, 2013 (GLOBE NEWSWIRE) -- Prosensa Holding N.V. (NASDAQ: RNA) today announced that Hans
GCP Schikan, Chief Executive Officer, will present a corporate
overview at the...
Prosensa Awarded EUR 6 million EU FP7 Research Grant
01. August 2013 08:00 ET
|
Prosensa Holding N.V.
Leiden, The Netherlands, Aug. 1, 2013 (GLOBE NEWSWIRE) -- Prosensa Holding N.V. (NASDAQ: RNA), the Dutch biopharmaceutical
company focusing on RNA-modulating therapeutics for rare diseases
with high...
Prosensa Holding B.V. Prices Initial Public Offering
27. Juni 2013 18:56 ET
|
Prosensa Holding N.V.
LEIDEN, the Netherlands, June 27, 2013 (GLOBE NEWSWIRE) -- Prosensa Holding B.V. ("Prosensa") announced today the pricing of its initial public offering of 6,000,000 of its ordinary shares at an...